Neurological Institute Outcomes
Surgical Quality Improvement
Neurosurgery Outcomes
January 1, 2022 – December 31, 2022
The American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP®) objectively measures and reports risk-adjusted surgical outcomes based on a defined sampling and abstraction methodology. These outcomes data reflect Cleveland Clinic’s overall neurosurgery ACS NSQIP performance benchmarked against 374 participating sites.
| Neurosurgery (374 Sites) | N | Observed | Expected |
|---|---|---|---|
| 30 Day Mortality | 265 | 2.26% | 2.82% |
| 30 Day Morbidity | 265 | 6.42% | 9.62% |
| Cardiac | 265 | 0.38% | 0.59% |
| Pneumonia | 264 | 1.14% | 2.34% |
| Unplanned Intubation | 263 | 2.28% | 1.77% |
| Ventilator > 48 Hours | 262 | 1.53% | 1.50% |
| Deep Vein Thrombosis (DVT) / Pulmonary Embolus | 265 | 4.15% | 3.94% |
| Renal Failure | 265 | 0.38% | 0.59% |
| Urinary Tract Infection (UTI) | 265 | 0.38% | 1.60% |
| Surgical Site Infection (SSI) | 265 | 2.26% | 2.37% |
| Sepsis | 265 | 1.89% | 1.78% |
| C.diff Colitis | 265 | 0.75% | 0.13% |
| Unplanned Reoperation | 265 | 3.40% | 5.08% |
| Unplanned Readmission | 265 | 9.06% | 9.39% |
American College of Surgeons National Surgical Quality Improvement Program, 2023.
ACS NSQIP® Semiannual Report July 3, 2023, Chicago: American College of Surgeons.
